altiratinib

[email protected]
altiratinib
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2014-08-19 00:00:00
Sponsor Deciphera Pharmaceuticals, LLC;643 Massachusetts, Suite 200;Lawrence, Kansas, 66044
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM